Awash in red ink, life sciences firm Avivagen seeks new CEO to spark scaleup bid

Cows eating
In financial filings this week, Ottawa-based company says it brought in $939,000 in revenues in its fiscal year ending Oct. 31, 2022, down from about $1.3 million the previous year.
Already an Insider? Log in

Get Instant Access to This Article

Become an Ottawa Business Journal Insider and get immediate access to all of our Insider-only content and much more.

Get our email updates

Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.